Market Research Reports and Industry Reports

Stratatech Corporation - Product Pipeline Review - 2015

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

Summary
 
 Global Markets Direct’s, ‘Stratatech Corporation - Product Pipeline Review - 2015’, provides an overview of the Stratatech Corporation’s pharmaceutical research and development focus.
 
 This report provides comprehensive information on the current therapeutic developmental pipeline of Stratatech Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
 
 Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
 
 The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
 
 Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Scope
 
 - The report provides brief overview of Stratatech Corporation including business description, key information and facts, and its locations and subsidiaries
 - The report reviews current pipeline of Stratatech Corporation’s human therapeutic division and enlists all their major and minor projects
 - The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
 - Special feature on out-licensed and partnered product portfolio
 - The report summarizes all the dormant and discontinued pipeline projects
 - Latest company statement
 - Latest news and deals relating to the Stratatech Corporation’s pipeline products
 
 Reasons to buy
 
 - Evaluate Stratatech Corporation’s strategic position with total access to detailed information on its product pipeline
 - Assess the growth potential of Stratatech Corporation in its therapy areas of focus
 - Identify new drug targets and therapeutic classes in the Stratatech Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
 - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
 - Develop strategic initiatives by understanding the focus areas of Stratatech Corporation and exploit collaboration and partnership opportunities
 - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
 - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Stratatech Corporation
 - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
 - Explore the dormant and discontinued projects of Stratatech Corporation and identify potential opportunities in those areas
 - Avoid Intellectual Property Rights related issues

 Table of Contents 2
 List of Tables 4
 List of Figures 4
 Stratatech Corporation Snapshot 5
 Stratatech Corporation Overview 5
 Key Information 5
 Key Facts 5
 Stratatech Corporation - Research and Development Overview 6
 Key Therapeutic Areas 6
 Stratatech Corporation - Pipeline Review 8
 Pipeline Products by Stage of Development 8
 Pipeline Products - Monotherapy 9
 Stratatech Corporation - Pipeline Products Glance 10
 Stratatech Corporation - Late Stage Pipeline Products 10
 Phase III Products/Combination Treatment Modalities 10
 Stratatech Corporation - Clinical Stage Pipeline Products 11
 Phase I Products/Combination Treatment Modalities 11
 Stratatech Corporation - Early Stage Pipeline Products 12
 Preclinical Products/Combination Treatment Modalities 12
 Discovery Products/Combination Treatment Modalities 13
 Stratatech Corporation - Drug Profiles 14
 StrataGraft Skin Tissue 14
 Product Description 14
 Mechanism of Action 14
 R&D Progress 14
 Cathelicidin 16
 Product Description 16
 Mechanism of Action 16
 R&D Progress 16
 Cell Therapy to Activate VEGF for Venous Leg Ulcers and Diabetic Foot Ulcers 18
 Product Description 18
 Mechanism of Action 18
 R&D Progress 18
 Interleukin-12 19
 Product Description 19
 Mechanism of Action 19
 R&D Progress 19
 Stratatech Corporation - Pipeline Analysis 20
 Stratatech Corporation - Pipeline Products by Target 20
 Stratatech Corporation - Pipeline Products by Molecule Type 21
 Stratatech Corporation - Pipeline Products by Mechanism of Action 22
 Stratatech Corporation - Locations And Subsidiaries 23
 Head Office 23
 Appendix 24
 Methodology 24
 Coverage 24
 Secondary Research 24
 Primary Research 24
 Expert Panel Validation 24
 Contact Us 24
 Disclaimer 25


List Of Tables

 Stratatech Corporation, Key Information 5
 Stratatech Corporation, Key Facts 5
 Stratatech Corporation - Pipeline by Indication, 2015 7
 Stratatech Corporation - Pipeline by Stage of Development, 2015 8
 Stratatech Corporation - Monotherapy Products in Pipeline, 2015 9
 Stratatech Corporation - Phase III, 2015 10
 Stratatech Corporation - Phase I, 2015 11
 Stratatech Corporation - Preclinical, 2015 12
 Stratatech Corporation - Discovery, 2015 13
 Stratatech Corporation - Pipeline by Target, 2015 20
 Stratatech Corporation - Pipeline by Molecule Type, 2015 21
 Stratatech Corporation - Pipeline Products by Mechanism of Action, 2015 22


List Of Figures

 Stratatech Corporation - Pipeline by Top 10 Indication, 2015 7
 Stratatech Corporation - Pipeline by Stage of Development, 2015 8
 Stratatech Corporation - Monotherapy Products in Pipeline, 2015 9
 Stratatech Corporation - Pipeline by Top 10 Target, 2015 20
 Stratatech Corporation - Pipeline by Top 10 Molecule Type, 2015 21
 Stratatech Corporation - Pipeline Products by Top 10 Mechanism of Action, 2015 22


Stratatech Corporation - Product Pipeline Review - 2015

   Global Markets Direct’s, ‘Stratatech Corporation - Product Pipeline Review - 2015’, provides an overview of the Stratatech Corporation’s pharmaceutical research and development focus.    This report provides comprehensive

USD 1500View Report

Sherritt International Corporation - Q1, 2015 Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Sherritt International Corporation - Q1, 2015 Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market

USD 200View Report

Sanchez Energy Corporation - Q4, 2014 Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Sanchez Energy Corporation - Q4, 2014 Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market

USD 200View Report

Rex Energy Corporation - Q4, 2014 Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Rex Energy Corporation - Q4, 2014 Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market

USD 200View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

Discount on PDF and Enterprise Wide Licence reports
  • PDF    $ 1500
  • Site Licence    $ 3000
  • Enterprise Wide Licence    $ 4500
$ 1500

Reports Details

Published Date : Jul 2015
No. of Pages :25
Country :Global
Category :Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment